A review on statins with a focus on type 2 diabetes
Statins are the most important lipid lowering drugs and their protective effects in primary or secondary cardiovascular diseases (CVDs) have been well documented. However, various number of evidences have revealed that the beneficial effects of statins regarding the CVDs are not only due to their bl...
Main Authors: | Vahideh Sadra, Mitar Niafar, Vahid Hosseini, Amir Mehdizadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences Press
2023-02-01
|
Series: | Journal of Research in Clinical Medicine |
Subjects: | |
Online Access: | https://jrcm.tbzmed.ac.ir/PDF/jrcm-11-3.pdf |
Similar Items
-
Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low‐Risk Population With Type 2 Diabetes Mellitus
by: Morten Malmborg, et al.
Published: (2021-07-01) -
Evaluation of Statin Indication and Dose Intensification Among Type 2 Diabetic Patients at a Tertiary Hospital
by: Fisseha PY, et al.
Published: (2024-03-01) -
STATINS AND THE RISK OF DIABETES MELLITUS
by: O. M. Drapkina
Published: (2015-09-01) -
Statins and diabetes mellitus: price of collaboration
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2012-06-01) -
National Trends in Statin Use in Lithuania from 2010 to 2021
by: Gytis Makarevičius, et al.
Published: (2022-12-01)